← FDA DRUG APPROVALS

FDA ANDA · ANDA212460

TRIAMCINOLONE ACETONIDE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA212460
TYPE
ANDA
ORIGINAL APPROVAL
2021-02-05
LATEST ACTION
2021-02-05
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.05% · OINTMENT · TOPICAL

Approval history

2021-02-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →